Sullivan & Cromwell Partners Ari Blaut and Benjamin Beller co-authored an article in Bloomberg Law discussing key points for creditors in light of the increase in in-court and out-of-court restructurings seen across life science companies. Ari and Ben highlight the unique considerations at play compared to bankruptcies in other industries, and discuss how secured creditors can maximize the expected value of their strategic decisions to ensure their objectives—not the typical playbook—dictate the course of the restructuring.
Read: “Health Care Operations & Compliance, Professional Perspective - Key Points for Creditors in Recent Restructurings of Life Sciences Companies”
Subscribe to stay current on S&C Insights.
Sending an e-mail through this web site does not create an attorney-client relationship. You should not send us any information through this web site that you would want treated confidentially.